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a  b  s  t  r  a  c  t
The  Fc  region  of  IgG  antibodies  (C2 and  C3  domains)  is  responsible  for effector  functions  such  as
antibody-dependent  cell-mediated  cytotoxicity  and  phagocytosis,  through  engagement  with  Fc  recep-
tors, although  the  ability  to elicit  these  functions  differs  between  the  four  human  IgG subclasses.  A  key
determinant  of  Fc  receptor  interactions  is  the  FG loop  in  the  C2  domain.  High  resolution  cryogenic
IgG4-Fc  crystal  structures  have  revealed  a unique  conformation  for this  loop,  which  could  contribute  to
the particular  biological  properties  of  this  subclass.  To  further  explore  the  conformation  of the  IgG4  C2
FG  loop  at near-physiological  temperature,  we  solved  a 2.7  Å  resolution  room  temperature  structure  of
recombinant  human  IgG4-Fc  from  crystals  analysed  in  situ.  The  C2 FG  loop  in  one  chain  differs  from  the
cryogenic  structure,  and  adopts  the  conserved  conformation  found  in  IgG1-Fc;  however,  this  conforma-
tion participates  in  extensive  crystal  packing  interactions.  On  the other  hand,  at room  temperature,  and
free from  any crystal  packing  interactions,  the  C2 FG  loop  in the  other  chain  adopts  the  conformation
previously  observed  in the  cryogenic  IgG4-Fc  structures,  despite  both  conformations  being  accessible.  The
room temperature  human  IgG4-Fc  structure  thus  provides  a more  complete  and  physiologically  relevant
description  of the  conformation  of this  functionally  critical  C2  FG loop.
© 2016  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
IgG effector functions, such as antibody-dependent cell-
mediated cytotoxicity, antibody-dependent cellular phagocytosis
and complement activation, are mediated by the antibody Fc region
(C2 and C3 domains). The IgG4 subclass binds certain Fc recep-
tors with lower afﬁnity than IgG1 and IgG3 (Bruhns et al., 2009), and
does not activate complement (van der Zee et al., 1986). Antibody
determinants that inﬂuence the afﬁnity for Fc  receptors include
sequence variation in the C2 domain and hinge region, and the
composition of the oligosaccharide moiety attached to the C2
domain (Canﬁeld and Morrison, 1991; Shields et al., 2002).
∗ Corresponding authors at: King’s College London, Randall Division of Cell and
Molecular Biophysics, New Hunt’s House, Guy’s Campus, London SE1 1UL, United
Kingdom.
E-mail addresses: anna.davies@kcl.ac.uk (A.M. Davies), brian.sutton@kcl.ac.uk
(B.J. Sutton).
The C2 domain FG loop (residues 325–331) plays a crucial role
in the interaction with Fc  receptors, in which Pro329 from the
FG loop forms a hydrophobic “proline sandwich” interaction with
two tryptophan residues from the receptor (Sondermann et al.,
2000), and is also involved in the interaction between IgG1/3 and
C1q (Canﬁeld and Morrison, 1991; Tao et al., 1991, 1993; Idusogie
et al., 2000). While the conformation of the C2 domain FG loop
is conserved in IgG1, high resolution cryogenic crystal structures
of IgG4-Fc revealed a different, unique conformation for the C2
FG loop, which would disrupt the interaction with Fc  receptors
(Davies et al., 2014b). Subsequent cryogenic crystal structures of
IgG4-Fc (Davies et al., 2014a) and intact IgG4 (Scapin et al., 2015)
revealed that the IgG4 C2 FG loop could also adopt the conserved
IgG1-like conformation. However, the role of the unique loop con-
formation in modulating the biological properties of IgG4, and
whether one, or both, conformations could be adopted at physi-
ological temperature, and in solution, remains unclear.
Using a technique to collect data from crystals in situ (Axford
et al., 2015), we solved a 2.7 Å resolution room temperature (RT)
structure of recombinant human IgG4-Fc. The RT IgG4-Fc structure
http://dx.doi.org/10.1016/j.molimm.2016.11.021
0161-5890/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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reveals conformational diversity in the C2 FG loop. In contrast to
the cryogenic structure, the FG loop adopts the IgG1-like confor-
mation in one C2 domain, with substantial changes to the crystal
packing interactions at the higher temperature which would pre-
clude the unique conformation due to steric clashes. On the other
hand, the FG loop from the other C2 domain is able to adopt either
conformation − in fact it adopts the unique, IgG4-like conforma-
tion at room temperature, a conformation that would disrupt the
interaction with Fc receptors.
2. Materials and methods
2.1. Protein production and crystallisation
Recombinant, glycosylated human IgG4-Fc was  produced and
crystals were grown as described previously (Davies et al., 2014b),
with the following modiﬁcation: a Greiner Bio-One CrystalQuickTM
X plate was set up using a reservoir volume of 20 L, and drops
comprising 0.5 L protein (3 mg/mL) and 0.5 L reservoir. Crystals
typically started to appear after one day.
2.2. Data collection, structure determination and reﬁnement
Data were collected at room temperature (293 K) at beamline
I03 at the Diamond Light Source (Harwell, UK) from crystals in situ.
Small wedges (typically 3◦−6◦) of data were collected from dif-
ferent crystals, or spatially distinct regions from a single crystal,
using an oscillation per image of 0.2◦. For multiple datasets col-
lected from a single crystal, the oscillation start angle for each
dataset was incremented by 2◦. Over 200 partial datasets from 48
isomorphous crystals were collected in this manner. Integration
was performed with XDS (Kabsch, 2010) within the xia2 package
(Winter, 2010) and further processing was carried out using POINT-
LESS (Evans, 2011), SORTMTZ, AIMLESS (Evans and Murshudov,
2013) and TRUNCATE (French and Wilson, 1978) from the CCP4
suite (Winn et al., 2011). Only the ﬁrst 10 images (2◦ of data)
from each partial dataset that had been successfully integrated
with XDS, with Batch Rmerge values of 40% or less, were typically
used for scaling, with 129 runs of data ﬁnally included. The struc-
ture was solved by molecular replacement with PHASER (McCoy
et al., 2007) using protein atoms from PDB: 4C54 as a search model,
with residues 325–331 omitted from the model. Reﬁnement was
performed with PHENIX (Adams et al., 2010), using the “Optimize
X-ray/stereochemistry weight” and “Optimize X-ray/ADP weight”
options, and manual model building was performed with Coot
(Emsley et al., 2010). For both chains of the asymmetric unit, the
C2 domain FG loop conformation was  validated by inspection of
2Fo-Fc and Fo-Fc electron density maps following reﬁnement with
residues 325–331 omitted from the model (Fig. 1). Structure quality
was assessed with MolProbity (Chen et al., 2010) within PHENIX.
Data processing and reﬁnement statistics are presented in Table 1.
Interfaces were analysed with PISA (Krissinel and Henrick, 2007)
and ﬁgures were produced with PyMOL (The PyMOL Molecular
Graphics System, Version 1.1r1, Schrödinger, LLC).
3. Results and discussion
3.1. Overall structure
The asymmetric unit of the room temperature (RT) recombinant
human IgG4-Fc crystal structure solved from crystals in situ con-
tains one Fc molecule, comprising two  chains (A and B). Residues
Gly236-Ser444 and Gly237-Ser444 were built for chains A and B,
respectively. A heptasaccharide core, covalently linked to Asn297
in the C2 domain, was modelled for each chain. Each oligosaccha-
ride moiety additionally contains a fucose residue attached to the
ﬁrst N-acetylglucosamine residue. The quality of the electron den-
sity map  is illustrated for the oligosaccharide moiety from chain A
in Fig. 2A.
The RT structure belongs to the same crystal form (space group P
21 21 21) previously reported for the cryogenic recombinant IgG4-
Fc crystal structure (Davies et al., 2014b), and the overall domain
topology is comparable. However, the C2 domains adopt a slightly
more “open” conformation at room temperature i.e. they are further
apart from one another compared with their position in the cryo-
genic structure (Fig. 2B). For example, the C atoms for Val323 are
34.8 Å and 36.0 Å apart in the cryogenic and RT structures, respec-
tively.
Despite belonging to the same crystal form, the b and c unit cell
dimensions in the RT structure (b = 81.93 Å, c = 103.88 Å) are ∼3 Å
and 6 Å longer, respectively, than those in the cryogenic recom-
binant IgG4-Fc structure (b = 78.97 Å, c = 97.88 Å). The longer unit
cell dimensions at room temperature are mostly attributed to a
conformational difference in the C2 FG loop in chain B.
3.2. Crystal packing interactions for the C2 domain of chain A
With the exception of residues Asp280-Val282, crystal packing
interactions for the C2 domain from chain A are similar in both
Fig. 1. Electron density for the C2 domain FG loop. (A) C2 FG loop from chain A. (B) C2 FG loop from chain B. Fo-Fc maps are shown, contoured at 2.5. Residues 325–331
were  omitted from the model prior to reﬁnement.
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Table  1
Data collection, processing and reﬁnement statistics.
Data collection
Number of crystals used 48
Number of datasets collected >200 partial datasets
Temperature (K) 293
Data processing
Space group P 212121
Unit cell dimensions
a, b, c (Å) 73.29, 81.93, 103.88
Resolution (Å) 48.35−2.70 (2.83−2.70)a
Completeness (%) 99.9 (99.9)a
Multiplicity 8.7 (8.9)a
Mean ((I)/(I)) 12.2 (2.0)a
CC1/2 0.992 (0.433)a
Rmerge (%) 17.1 (288.4)a
Rpim (%) 6.0 (98.9) a
Wilson B factor (Å2) 77.7
Reﬁnement
Rwork/Rfree (%)b 17.53/23.13
RMSD
Bond lengths (Å) 0.003
Bond angles (◦) 0.540
Coordinate error (Å) 0.39
No.  of atoms
Proteinc 3270
Oligosaccharide A/B 99/99
Solvent 20
Ave. B factor (Å2)
Protein: C2 A/B 74.9/115.3
Protein: C3 A/B 72.3/69.8
Oligosaccharide A/B 86.8/143.3
Solvent 60.6
Ramachandran plotd
Favoured (%) 98.6
Allowed (%) 100
a Values in parentheses are for the highest resolution shell.
b Rfree set comprises 5% reﬂections.
c Includes alternative conformations.
d Ramachandran plot generated by MolProbity (Chen et al., 2010).
RT and cryogenic structures (Fig. 3A). At room temperature, Gln418
from the C3 domain of a symmetry-related molecule packs against
Asp280-Val282, forming a 96 Å2 interface (105 Å2 if disordered
atoms are included) (Fig. 3B). On the other hand, crystal packing in
the cryogenic structure is such that the relative position of the helix
containing Gln418 is altered; instead, Lys414 packs against Gly281,
and Gln418 forms a hydrogen bond with the Asp280 carbonyl atom,
creating a larger interface of 132 Å2 (Fig. 3C).
3.3. At room temperature, the C2 domain FG loop adopts the
unique, IgG4-like conformation in chain A
The C2 FG loop conformation is conserved in both unbound
human IgG1-Fc and receptor-bound IgG1-Fc crystal structures
(Davies and Sutton, 2015). However, the cryogenic crystal structure
for human IgG4-Fc revealed a different C2 FG loop conformation,
which would disrupt the interaction with Fc  receptors (Fig. 3D)
(Davies et al., 2014b). We  now report that at room temperature,
the C2 FG loop adopts the unique, IgG4-like conformation (Figs.1A
and 3D) as seen in the cryogenic structure.
At room temperature, average B factors for chain A chain C2
FG loop residues are ∼1.8 fold higher than the C2 domain aver-
age, a value comparable to the cryogenic structure average (∼1.7
fold higher), but in contrast to the cryogenic structure, the Lys326
and Pro329 side chain atoms are disordered at room temperature.
Although the IgG1-like conformation is not precluded in chain A, we
did not observe electron density to suggest that the loop samples
both IgG1-like and IgG4-like conformations.
3.4. Interplay between crystal packing and C2 domain FG loop
conformation in chain B
Substantial crystal packing interactions occur between the C2
domain FG loop from chain B and the C3 domain from a symmetry-
related molecule in the P 21 21 21 crystal form (Fig. 4A). In the
Fig. 2. Overall structure of human IgG4-Fc solved at room temperature from crystals in situ. (A) Electron density for the oligosaccharide moiety from chain A. A 2Fo-Fc map
is  shown, contoured at 1. The oligosaccharide residues are labelled as follows: BMA, -d-mannose; NAG, N-acetylglucosamine; MAN; -d-mannose, FUC, -l-fucose. (B)
Overall structure of human IgG4-Fc. Chains A and B for the room temperature structure are colored blue and purple, respectively. For comparison, the cryogenic IgG4-Fc
structure (Davies et al., 2014b) is shown in gray. The disposition of the C2 domain from chain A differs when the two structures are superposed (RMSD 0.36 Å for chain B
C3  domain C atoms). The positions of the C2 BC and FG loops are indicated for chain B. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web  version of this article.)
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Fig. 3. Crystal packing and C2 domain FG loop conformation (chain A). (A) With the exception of residues Asp280-Val282, crystal packing interactions in the room
temperature (RT) (blue) and cryogenic (yellow) (Davies et al., 2014b) IgG4-Fc structures, which do not involve the FG loop, are similar. (B) In the RT structure (blue) Gln418
from  the C3 domain of a symmetry-related molecule (gray) packs against residues Asp280, Gly281 and Val282. (C) In the cryogenic structure (yellow), Lys414 packs against
Gly281, and Gln418 forms a hydrogen bond with the Asp280 carbonyl atom. (D) In chain A of the RT (blue) and cryogenic (yellow) structures, the C2 FG loop from chain
A  adopts a different conformation to the conserved conformation found in IgG1 (gray) (Ferrara et al., 2011). Figures (A–C) were generated after superposition on the C2
domain from chain A. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web  version of this article.)
cryogenic structure, the nature of these interactions are such that
either IgG1-like or IgG4-like conformations are accessible, but the
loop adopts the unique, IgG4-like conformation (Fig. 4B). On the
other hand, and in contrast to the cryogenic structure, the FG loop
adopts the conserved IgG1-like conformation at room tempera-
ture (Fig. 4C); steric clashes with the symmetry-related molecule
preclude the IgG4-like conformation (Fig. 4A).
At room temperature, with the FG loop in an IgG1-like con-
formation, a 161 Å2 interface (182 Å2 if disordered atoms are
modelled) with the symmetry-related molecule includes: three
hydrogen bonds; contacts between main chain atoms from residues
325 and 328–330, and main chain and side chain atoms from
the symmetry-related C3 domain; packing of the Ser330 side
chain against Thr359 and Lys360 main chain and side chain atoms
(Fig. 4C). In the cryogenic structure, with the FG loop in an
IgG4-like conformation, an even larger, 288 Å2 interface (295 Å2
if disordered atoms are modelled) includes: ﬁve hydrogen bonds;
contacts between main atoms from residues 325 and 327–330,
and main chain and side chain atoms from the symmetry-related
C3 domain; packing of the Ser330 side chain against Thr359 and
Lys360 main chain atoms, and Pro329 against Gln362 (Fig. 4B).
Strikingly, as the contact area with the symmetry-related
molecule increases upon cryocooling, the crystal lattice contracts,
reducing c by 6 Å, accommodating the different loop conformation
(Fig. 4A).
3.5. C2 domain BC loop conformation
The C2 domain BC loop (residues 264–273) also plays a role in
the interaction between IgG and Fc receptors (Davies and Sutton,
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Fig. 4. Crystal packing and C2 domain FG loop conformation (chain B). (A) The C2 domain FG loop from chain B adopts a different conformation in the room temperature
(RT)  (blue) and cryogenic (yellow) (Davies et al., 2014b) IgG4-Fc structures. In the RT structure, the C2 FG loop adopts the conserved conformation found in IgG1. In the
cryogenic structure, the unique, IgG4-like conformation would clash with the C3 domain from a symmetry-related molecule (C3-symm), and the crystal packing alters
to  accommodate this conformation, with a reduction in the c unit cell dimension, the direction of which is indicated by an arrow. (B) In the cryogenic structure, the C2 FG
loop  (yellow) adopts the unique, IgG4-like conformation and forms a 288 Å2 interface with a symmetry-related molecule (gray). (C) In the RT structure, the IgG1-like C2 FG
loop  (blue) forms a 161 Å2 interface with a symmetry-related molecule (gray). Figure (A) was generated after superposition of the C3 domains from the room temperature
and  cryogenic structures. Figures (B) and (C) were generated after superposition on the C2 domain from chain B. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
2015; Kiyoshi et al., 2015; Oganesyan et al., 2015), and IgG and
C1q (Idusogie et al., 2000). This loop conformation is conserved in
unbound IgG1-Fc, and the majority of IgG1-Fc/Fc receptor com-
plex structures, but the cryogenic IgG4-Fc structure (P 21 21 21
crystal form) revealed a different conformation, due to isomeri-
sation of Pro271 (Davies and Sutton, 2015). Crystal structures of
IgG1-Fc in complex with FcRI later demonstrated that the IgG1
C2 BC loop could also adopt this different conformation, which
facilitates the formation of a hydrogen bond with the receptor;
however, the C2 FG loop conformation was conserved (IgG1-like)
(Kiyoshi et al., 2015; Oganesyan et al., 2015). Together with the
deglycosylated IgG4-Fc structure (Davies et al., 2014a), in which an
IgG4-like FG loop conformation and IgG1-like BC loop conformation
were observed in the same C2 domain, the IgG1-Fc/FcRI complex
structures suggest that the C2 BC and FG loop conformations are
independent of one another (Davies and Sutton, 2015).
In chain A of the RT IgG4-Fc structure, the C2 BC (and FG) loop
adopts the same conformation observed in the cryogenic structure
(Fig. 5A). On the other hand, the C2 BC (and FG) loop from chain
B adopts the conformation which is conserved in the majority of
IgG1-Fc structures (Fig. 5B). Thus, while the C2 BC and FG loops
have been observed to independently adopt conserved and non-
conserved conformations within the same domain, we  do not see
any evidence for this in the RT IgG4-Fc structure.
3.6. Implications of the C2 domain FG loop conformation
The ability of the IgG4 C2 domain FG loop to adopt two dif-
ferent conformations, one IgG1-like and one IgG4-like, as observed
in chain B of the RT and cryogenic IgG4-Fc structures respectively,
was previously seen in the four independent chains of the cryogenic
structure of deglycosylated human IgG4-Fc, which crystallised in
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Fig. 5. C2 domain BC loop conformation. (A) The C2 domain BC and FG loops
from chain A adopt similar conformations in the room temperature (RT) (blue) and
cryogenic (yellow) IgG4-Fc structures (Davies et al., 2014b). (B) The C2 domain
BC  and FG loop conformations from chain B of the RT structure (blue) differ from
those in the cryogenic structure (yellow), and are more akin to the conformations
typically observed in IgG1-Fc (gray) (Ferrara et al., 2011). (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web  version
of  this article.)
a different crystal form (P 6 2 2) (Davies et al., 2014a). However,
in these chains, both loop conformations are involved in crys-
tal packing interactions (with an average area of ∼147 Å2). More
recently, a crystal structure of intact IgG4, solved under cryogenic
conditions, revealed an IgG1-like C2 FG loop conformation in one
chain, in the absence of crystal packing interactions (Scapin et al.,
2015).
By contrast, in the P 21 21 21 crystal form, chain A forms only
minor interactions with a symmetry-related molecule. Under cryo-
genic conditions, Leu328 from the IgG4-like C2 FG loop forms
an interface of ∼35 Å2 with Gln311 from a symmetry-related
molecule; this interaction is ∼4 Å2 at room temperature, attributed
to disorder of the Gln311 side chain and differences in overall
packing (although, the interaction area is ∼16 Å2 if the disordered
side chain is modelled). These values suggest that the C2 FG loop
conformation for this chain more closely reﬂects the situation in
solution.
Importantly, the RT IgG4-Fc crystal structure, in which either
IgG1-like or IgG4-like conformations are accessible in chain A,
reveals that the C2 FG does not sample multiple conformations
at room temperature. In fact, the unique, IgG4-like C2 FG loop
conformation is adopted, which would disrupt the interaction with
Fc receptors, in contrast to the conserved, IgG1-like conformation,
which would engage Fc receptors through the “proline sandwich”
interaction.
The recent crystal structure of intact IgG4 (Scapin et al., 2015)
revealed an unusual position for one of the C2 domains, which was
rotated by ∼120◦, exposing the carbohydrate moiety covalently
attached to Asn297. In the FG loop from this domain, torsion angles
for Lys326 () (103◦), Gly327 () (132◦) and Ser331 () (−133◦)
are comparable to the range of torsion angle values for the unique
IgG4-like conformation in the cryogenic and RT IgG4-Fc structures
[Lys326 (), 102 to 125◦; Gly327 () 77 to 128◦; Ser331(), −143
to −160◦], which differ from the range of typical torsion angle val-
ues found in high resolution IgG1-Fc structures [Lys326 (), −3
to −41◦; Ala327 (), −66 to −103◦; Pro331 (), −41 to −71◦]. By
contrast, the Ser330 () torsion angle (−111◦) is more akin to the
range of values for Ala330 () in IgG1-Fc (-115 to −159◦), which
differs from the range of values for Ser330 () when the unique
IgG4-like conformation is adopted (-61 to −81◦). When the rotated
C2 domain is superposed in turn on C2 domains from IgG1-Fc
and IgG4-Fc structures, the overall position of Pro329 from the FG
loop is closer to the position of Pro329 in IgG1-Fc. However, when
the FG loop alone is compared, the positions of Lys326 and Gly327
main chain atoms are more similar to those for the unique IgG4-
like conformation. The IgG4-like conformation that would disrupt
the “proline sandwich” interaction with the receptor is precluded
in this rotated domain, as the FG loop packs against the other C2
domain. However, this raises an intriguing possibility that if this
conformation were adopted, it could modulate the position of the
rotated C2 domain, and inﬂuence overall IgG4 structure.
Although both IgG1-like and IgG4-like C2 FG loop conforma-
tions are accessible in chain A, the unique IgG4-like conformation
is adopted at both temperatures when crystal packing interactions
do not pose any steric restrictions; the room temperature struc-
ture could reﬂect the loop conformation in solution, although we
cannot rule out that the loop is more dynamic under these con-
ditions and adopts different conformations. Indeed, both IgG1-like
and IgG4-like C2 FG loop conformations bury a similar surface
area against the rest of the C2 domain. The IgG1-like loop confor-
mation is clearly accessible, but the inﬂuence exerted by the local
environment, such as the packing interactions with a symmetry-
related molecule in chain B, on the energy barrier between the two
conformations, and their relative energies, requires further explo-
ration.
4. Conclusions
In summary, we solved the room temperature structure of
recombinant human IgG4-Fc at 2.7 Å resolution from crystals in situ.
Comparison of this structure with the recombinant human IgG4-Fc
structure previously solved in the same space group under cryo-
genic conditions revealed that the C2 FG loop from one chain
(chain B) adopts the conserved IgG1-like conformation at room
temperature, and the unique IgG4-like conformation under cryo-
genic conditions. In this chain, the two  loop conformations are
associated with substantial changes in crystal packing interactions
at the two different temperatures. However, our structure also
demonstrates that when either conformation is accessible, the C2
FG loop from the other chain (chain A) does not sample multiple
conformations, and adopts the unique, IgG4-like conformation at
near-physiological temperature.
Accession number
Coordinates and structure factors have been deposited in the
Protein Data Bank with accession number PDB: 5LG1.
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